Literature DB >> 13776665

Serum enzyme activity in muscular dystrophy.

W H THOMSON, P LEYBURN, J N WALTON.   

Abstract

Entities:  

Keywords:  ENZYMES/blood; MUSCULAR DYSTROPHY/blood

Mesh：

Substances：

Year:  1960        PMID： 13776665      PMCID： PMC2097052          DOI： 10.1136/bmj.2.5208.1276

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  31 in total

1.  [Blood transaminases in patients with dystrophia myotonica].

Authors:  E KUHN; W WORNER
Journal:  Z Klin Med       Date:  1959

2.  Glycogenolytic enzymes in human progressive muscular dystrophy.

Authors:  G SCHAPIRA; J C DREYFUS; F SCHAPIRA; J KRUH
Journal:  Am J Phys Med       Date:  1955-02

3.  Reactive changes of enzyme activities in serum and liver as symptoms of acute syndrome.

Authors:  W H HAUSS; H J LEPPELMANN
Journal:  Ann N Y Acad Sci       Date:  1958-10-13       Impact factor: 5.691

4.  Multiple serial enzyme studies in acute myocardial infarction.

Authors:  N R ROWELL; A J SMITH
Journal:  Br Med J       Date:  1959-09-19

5.  Movement of aldolase from excised rat diaphragm.

Authors:  K L ZIERLER
Journal:  Am J Physiol       Date:  1956-04

6.  [Not Available].

Authors:  J C DREYFUS; G SCHAPIRA
Journal:  C R Seances Soc Biol Fil       Date:  1955-11

7.  Some alterations in serum enzymes in progressive muscular dystrophy.

Authors:  A A WHITE; W C HESS
Journal:  Proc Soc Exp Biol Med       Date:  1957-03

8.  The serum aldolase level in acute myocardial infarction.

Authors:  B W VOLK; S LOSNER; S M ARONSON; H LEW
Journal:  Am J Med Sci       Date:  1956-07       Impact factor: 2.378

9.  The clinical significance of serum aldolase.

Authors:  J A SIBLEY; G A FLEISHER
Journal:  Proc Staff Meet Mayo Clin       Date:  1954-11-10

10.  Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction.

Authors:  J S LADUE; F WROBLEWSKI; A KARMEN
Journal:  Science       Date:  1954-09-24       Impact factor: 47.728
View more
  14 in total

1.  SERUM ENZYME STUDIES IN MUSCLE DISEASE. II. SERUM CREATINE KINASE ACTIVITY IN MUSCULAR DYSTROPHY AND IN OTHER MYOPATHIC AND NEUROPATHIC DISORDERS.

Authors:  J M PEARCE; R J PENNINGTON; J N WALTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-04       Impact factor: 10.154

2.  SERUM ENZYME STUDIES IN MUSCLE DISEASE. I. VARIATIONS IN SERUM CREATINE KINASE ACTIVITY IN NORMAL INDIVIDUALS.

Authors:  J M PEARCE; R J PENNINGTON; J N WALTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-02       Impact factor: 10.154

3.  SERUM LEVELS OF CREATINE PHOSPHOKINASE.

Authors:  P D GRIFFITHS
Journal:  J Clin Pathol       Date:  1964-01       Impact factor: 3.411

Review 4.  MUSCULAR DYSTROPHY: SOME RECENT ADVANCES IN KNOWLEDGE.

Authors:  J N WALTON
Journal:  Br Med J       Date:  1964-05-23

5.  Sources of error in the biochemical diagnosis of muscular dystrophy.

Authors:  W A THOMSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-08       Impact factor: 10.154

6.  Serum enzyme changes in muscle disease and their relation to tissue change.

Authors:  B P HUGHES
Journal:  Proc R Soc Med       Date:  1963-03

7.  Skeletal muscle glycogenosis: an investigation of two dissimilar cases.

Authors:  W H THOMSON; J C MACLAURIN; J W PRINEAS
Journal:  J Neurol Neurosurg Psychiatry       Date:  1963-02       Impact factor: 10.154

8.  Dystrophia myotonica in association with mental defect.

Authors:  R GIBSON
Journal:  Can Med Assoc J       Date:  1961-06-03       Impact factor: 8.262

9.  Progressive Muscular Dystrophy.

Authors: 
Journal:  Br Med J       Date:  1962-06-23

10.  Some Biochemical Aspects of the Myopathies.

Authors:  B P Hughes
Journal:  Postgrad Med J       Date:  1965-06       Impact factor: 2.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.